ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 12, 2011, Pages 1091-1097

  Nakayama, Akiyoshi ^a   Matsuo, Hirotaka ^a   Takada, Tappei ^b   Ichida, Kimiyoshi ^c,d   Nakamura, Takahiro ^a,e   Ikebuchi, Yuki ^b   Ito, Kousei ^b   Hosoya, Tatsuo ^d   Kanai, Yoshikatsu ^f   Suzuki, Hiroshi ^b   Shinomiya, Nariyoshi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; ESTRONE SULFATE; URATE; URIC ACID; ZIDOVUDINE;

ALLELE; APICAL MEMBRANE; ARTICLE; GENE MUTATION; HUMAN; HYPERURICEMIA; INTESTINE; KIDNEY; LIVER; MAJOR CLINICAL STUDY; MEMBRANE VESICLE; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; URIC ACID BLOOD LEVEL;

ATP-BINDING CASSETTE TRANSPORTERS; HUMANS; HYPERURICEMIA; NEOPLASM PROTEINS; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, SINGLE NUCLEOTIDE; URIC ACID;

EID: 84862969715     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.633953     Document Type: Article

References (20)

1. Cheng, L. S.; Chiang, S. L.; Tu, H. P.; Chang, S. J.; Wang, T. N.; Ko, A. M.; Chakraborty, R.; Ko, Y. C. Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am. J. Hum. Genet. 2004, 75, 498-503. (Pubitemid 39115318)
2. Dehghan, A.; Köttgen, A.; Yang, Q.; Hwang, S. J.; Kao, W. L.; Rivadeneira, F.; Boerwinkle, E.; Levy, D.; Hofman, A.; Astor, B. C.; Benjamin, E. J.; van Duijn, C. M.; Witteman, J. C.; Coresh, J.; Fox, C. S. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008, 372, 1953-1961.
3. Robey, R. W.; Polgar, O.; Deeken, J.; To, K. W.; Bates, S. E. ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev. 2007, 26, 39-57. (Pubitemid 46452182)
4. Kondo, C.; Suzuki, H.; Itoda, M.; Ozawa, S.; Sawada, J.; Kobayashi, D.; Ieiri, I.; Mine, K.; Ohtsubo, K.; Sugiyama, Y. Functional analysis of SNPs variants of BCRP/ABCG2. Pharm. Res. 2004, 21, 1895-1903. (Pubitemid 39390103)
5. Takada, T.; Weiss, H. M.; Kretz, O.; Gross, G.; Sugiyama, Y. Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154. Drug Metab. Dispos. 2004, 32, 1272-1278. (Pubitemid 39410912)
6. Pan, G.; Giri, N.; Elmquist, W. F. Abcg2/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine. Drug Metab. Dispos. 2007, 35, 1165-1173. (Pubitemid 46956438)
7. Maekawa, K.; Itoda, M.; Sai, K.; Saito, Y.; Kaniwa, N.; Shirao, K.; Hamaguchi, T.; Kunitoh, H.; Yamamoto, N.; Tamura, T.; Minami, H.; Kubota, K.; Ohtsu, A.; Yoshida, T.; Saijo, N.; Kamatani, N.; Ozawa, S.; Sawada, J. Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population. Drug Metab. Pharmacokinet. 2006, 21, 109-121.
8. Matsuo, H.; Takada, T.; Ichida, K.; Nakamura, T.; Nakayama, A.; Ikebuchi, Y.; Ito, K.; Kusanagi, Y.; Chiba, T.; Tadokoro, S.; Takada, Y.; Oikawa, Y.; Inoue, H.; Suzuki, K.; Okada, R.; Nishiyama, J.; Domoto, H.; Watanabe, S.; Fujita, M.; Morimoto, Y.; Naito, M.; Nishio, K.; Hishida, A.; Wakai, K.; Asai, Y.; Niwa, K.; Kamakura, K.; Nonoyama, S.; Sakurai, Y.; Hosoya, T.; Kanai, Y.; Suzuki, H.; Hamajima, N.; Shinomiya, N. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci. Transl. Med. 2009, 1, 5ra11.
9. Zhang, W.; Yu, B. N.; He, Y. J.; Fan, L.; Li, Q.; Liu, Z. Q.; Wang, A.; Liu, Y. L.; Tan, Z. R.; Fen, J.; Huang, Y. F.; Zhou, H. H. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin. Chim. Acta 2006, 373, 99-103. (Pubitemid 44292182)
10. Burger, H.; van Tol, H.; Boersma, A. W.; Brok, M.; Wiemer, E. A.; Stoter, G.; Nooter, K. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood 2004, 104, 2940-2942. (Pubitemid 39434984)
11. Cusatis, G.; Gregorc, V.; Li, J.; Spreafico, A.; Ingersoll, R. G.; Verweij, J.; Ludovini, V.; Villa, E.; Hidalgo, M.; Sparreboom, A.; Baker, S. D. Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J. Natl. Cancer Inst. 2006, 98, 1739-1742. (Pubitemid 44942712)
12. Jonker, J. W.; Buitelaar, M.; Wagenaar, E.; Van der Valk, M. A.; Scheffer, G. L.; Scheper, R. J.; Plosch, T.; Kuipers, F.; Elferink, R. P.; Rosing, H.; Beijnen, J. H.; Schinkel, A. H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 15649-15654. (Pubitemid 35403986)
13. Enomoto, A.; Kimura, H.; Chairoungdua, A.; Shigeta, Y.; Jutabha, P.; Cha, S. H.; Hosoyamada, M.; Takeda, M.; Sekine, T.; Igarashi, T.; Matsuo, H.; Kikuchi, Y.; Oda, T.; Ichida, K.; Hosoya, T.; Shimokata, K.; Niwa, T.; Kanai, Y.; Endou, H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002, 417, 447-452. (Pubitemid 34563537)
14. Matsuo, H.; Chiba, T.; Nagamori, S.; Nakayama, A.; Domoto, H.; Phetdee, K.; Wiriyasermkul, P.; Kikuchi, Y.; Oda, T.; Nishiyama, J.; Nakamura, T.; Morimoto, Y.; Kamakura, K.; Sakurai, Y.; Nonoyama, S.; Kanai, Y.; Shinomiya, N. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am. J. Hum. Genet. 2008, 83, 744-751.
15. Huls, M.; Brown, C. D.; Windass, A. S.; Sayer, R.; van den Heuvel, J. J.; Heemskerk, S.; Russel, F. G.; Masereeuw, R. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 2008, 73, 220-225.
16. Maliepaard, M.; Scheffer, G. L.; Faneyte, I. F.; van Gastelen, M. A.; Pijnenborg, A. C.; Schinkel, A. H.; van De Vijver, M. J.; Scheper, R. J.; Schellens, J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001, 61, 3458-3464. (Pubitemid 32695041)
17. Lemos, C.; Jansen, G.; Peters, G. J. Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors. Br. J. Cancer 2008, 98, 857-862. (Pubitemid 351341599)
18. Mogi, M.; Yang, J.; Lambert, J. F.; Colvin, G. A.; Shiojima, I.; Skurk, C.; Summer, R.; Fine, A.; Quesenberry, P. J.; Walsh, K. Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J. Biol. Chem. 2003, 278, 39068-39075. (Pubitemid 37221810)
19. Takada, T.; Suzuki, H.; Gotoh, Y.; Sugiyama, Y. Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells. Drug Metab. Dispos. 2005, 33, 905-909. (Pubitemid 41002770)
20. Woodward, O. M.; Köttgen, A.; Coresh, J.; Boerwinkle, E.; Guggino, W. B.; Köttgen, M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 10338-10342.